Journal of Yeungnam Medical Science

Volume 37(4); October 2020

Editorial

Advances in the science and treatment of respiratory diseases: Jin Hong Chung; Yeungnam Univ J Med. 2020;37(4):251-252. Published online September 2, 2020; DOI: https://doi.org/10.12701/yujm.2020.00661

6,564 View
114 Download

PDF

Focused Review articles

Pulmonary and Respiratory Medicine
An update on the role of bronchoscopy in the diagnosis of pulmonary disease: June Hong Ahn; Yeungnam Univ J Med. 2020;37(4):253-261. Published online August 28, 2020; DOI: https://doi.org/10.12701/yujm.2020.00584

19,826 View
296 Download
20 Crossref

Abstract PDF

Bronchoscopy has evolved over the past few decades and has been used by respiratory physicians to diagnose various airway and lung diseases. With the popularization of medical check-ups and growing interest in health, early diagnosis of lung diseases is essential. With the development of endobronchial ultrasound, ultrathin bronchoscopy, and electromagnetic navigational bronchoscopy, bronchoscopy has been able to widen its scope in diagnosing pulmonary diseases. In this review, we have described the brief history, role, and complications of bronchoscopy used in diagnosing pulmonary lesions, from simple flexible bronchoscopy to bronchoscopy combined with several up-to-date technologies.

Citations

Citations to this article as recorded by

Bronchoscopic manifestations and epidemiological characteristics of lymph node fistula-type tracheobronchial tuberculosis in Hunan Province, China (2019–2023)
Li Luo, Lei Zhou, Linzi Luo, Quhua Yin, Zhibin Lu, Dan Feng, Qingqing Zeng, Yangbao Xiao, Jun Liang
BMC Infectious Diseases.2026;[Epub] CrossRef
Performance Characteristics and 2-Year Outcomes of Digital Tomosynthesis-Assisted Electromagnetic Navigation Bronchoscopy in a Community Hospital
Brandon T. Rapier, Elizabeth M. Sain, Michael J. Forte, Anuja L. Sarode, Amber E. Kerstetter-Fogle, Valerie Slezak, Brian D. Bauman
CHEST Pulmonary.2026; : 100269. CrossRef
Immune profile and routine laboratory indicator-based machine learning for prediction of lung cancer
Yi Huang, Kaishan Jiang, Xiaochen Wang, Siyu Zou, Ziyong Sun, Shiji Wu, Bin Wang, Hongyan Hou, Feng Wang
Computers in Biology and Medicine.2025; 190: 110111. CrossRef
Endobronchial hamartomas as a rare cause of chronic cough
Selsabil Daboussi, Asma Saidane, Abdellatif Syrine, Samira Mhamdi, Faten Gargouri, Houssem Messaoudi, Saber Hachicha, Chiraz Aichaouia, Zied Moatemri
Respiratory Medicine Case Reports.2025; 55: 102210. CrossRef
Application value of fibro-bronchoscopic cryosurgery combined with medication in the treatment of tracheobronchial tuberculosis
Yue-Ying Zhou, Hui-Juan Li, Kai-Jia Wu, Ji-Chan Shi, Xian-Gao Jiang, Gui-Qing He, Ning Pan, Chao-Chao Qiu, Hong-Ye Ning, Zheng-Xing Wu
BMC Surgery.2025;[Epub] CrossRef
Effectiveness of Oral Prophylactic Antibiotics for Diagnostic Bronchoscopy: A Nationwide Database Study
Tomohiro Akaba, Taisuke Jo, Jun Suzuki, Yuya Kimura, Hiroki Matsui, Kiyohide Fushimi, Etsuko Tagaya, Hideo Yasunaga
Annals of the American Thoracic Society.2025; 22(5): 707. CrossRef
Differential Diagnosis of Peripheral Lung Lesions: Capabilities and Limitations of Current Methods
R. N. Islamov, R. A. Sharipov, M. A. Bagirov, R. K. Tukfatullin, G. V. Chitorelidze, E. V. Pavlova, R. K. Yagafarova
Creative surgery and oncology.2025; 15(2): 160. CrossRef
Flexible Bronchoscopy and Non-Small-Cell Lung Cancer Staging: A Narrative Review of Modern Techniques for Optimized Clinical Decision-Making
Simona-Maria Roșu, Denisa Maria Mitroi, Oana Maria Catană, Viorel Biciușcă, Sorina Ionelia Stan, Beatrice Mahler, Oana-Andreea Parliteanu, Adina Andreea Mirea, Mara Amalia Bălteanu
Journal of Clinical Medicine.2025; 14(16): 5773. CrossRef
Geographic variation in bronchoscopy use across Japan: A nationwide analysis using administrative claims data
Tomohiro Akaba, Ken Arimura, Keiko Kan-o, Miki Kubo, Mitsuko Kondo, Musashi Ueda, Osamitsu Yagi, Atsushi Kurokawa, Naoko Kawashima, Yutaro Horie, Yuno Shiota, Etsuko Tagaya
Respiratory Investigation.2025; 63(6): 1174. CrossRef
Deep-learning-assisted disposable bronchoscopy with enhanced image quality
Ang Li, Ming Lei, Zachary Burns, George Cheng, Zhaowei Liu
Biomedical Optics Express.2025; 16(11): 4243. CrossRef
Application of fiberoptic bronchoscopy in the diagnosis and treatment of pneumonia in children
He Zhang, De-Xing Wang, Hai-Ming Yu
Srpski arhiv za celokupno lekarstvo.2025; 153(9-10): 504. CrossRef
Disposable Versus Reusable Bronchoscopes: A Narrative Review of Cost-effectiveness, Risk of Cross-contamination and Environmental Impact
Illaa Smesseim, Johannes M.A. Daniels, Jouke Annema, Peter I. Bonta, Dirk-Jan Slebos
Archivos de Bronconeumología.2024; 60(4): 250. CrossRef
Applications of Machine Learning in Cancer Imaging: A Review of Diagnostic Methods for Six Major Cancer Types
Andreea Ionela Dumachi, Cătălin Buiu
Electronics.2024; 13(23): 4697. CrossRef
Flexible bronchoscopy indications and outcomes between indigenous and non‐indigenous patients in the Northern Territory of Australia
Mohammad M. Seyedshahabedin, Timothy P. Howarth, Lin Mo, Edwina Biancardi, Subash S. Heraganahally
Internal Medicine Journal.2023; 53(9): 1634. CrossRef
Endobronchial ultrasound‐guided re‐biopsy of non–small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatment
Kyung Soo Hong, Jinmo Cho, Jong Geol Jang, Min Hye Jang, June Hong Ahn
Thoracic Cancer.2023; 14(4): 363. CrossRef
Observational findings of transbronchial lung biopsy in patients with interstitial lung disease: a retrospective study in Aleppo University Hospital
Fateh Kashkash, Abdullah Khorri
Annals of Medicine & Surgery.2023; 85(2): 146. CrossRef
Invasive Diagnostic Procedures from Bronchoscopy to Surgical Biopsy—Optimization of Non-Small Cell Lung Cancer Samples for Molecular Testing
Nensi Lalić, Aleksandra Lovrenski, Miroslav Ilić, Olivera Ivanov, Marko Bojović, Ivica Lalić, Spasoje Popević, Mihailo Stjepanović, Nataša Janjić
Medicina.2023; 59(10): 1723. CrossRef
Utility of Radial Probe Endobronchial Ultrasound Guided Transbronchial Lung Biopsy in Bronchus Sign Negative Peripheral Pulmonary Lesions
Kyung Soo Hong, Kwan Ho Lee, Jin Hong Chung, Kyeong-Cheol Shin, Hyun Jung Jin, Jong Geol Jang, June Hong Ahn
Journal of Korean Medical Science.2021;[Epub] CrossRef
Radial Probe Endobronchial Ultrasound Using Guide Sheath-Guided Transbronchial Lung Biopsy in Peripheral Pulmonary Lesions without Fluoroscopy
Kyung Soo Hong, Heeyun Ahn, Kwan Ho Lee, Jin Hong Chung, Kyeong-Cheol Shin, Hyun Jung Jin, Jong Geol Jang, Seok Soo Lee, Min Hye Jang, June Hong Ahn
Tuberculosis and Respiratory Diseases.2021; 84(4): 282. CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef

Pulmonary and Respiratory Medicine
Biological treatments for severe asthma: Hyun Jung Jin; Yeungnam Univ J Med. 2020;37(4):262-268. Published online September 11, 2020; DOI: https://doi.org/10.12701/yujm.2020.00647

11,428 View
195 Download
14 Crossref

Abstract PDF

Severe asthma patients comprise about 3% to 13% of all asthma patients, but they have higher hospital utilization rates and higher medical costs than those of nonsevere asthma patients. Treatment methods for severe asthma patients are still lacking; however, the recent development of biologics is expected to have a positive effect. The biological therapies developed so far are mainly aimed at treating asthma patients with type 2 inflammation. These biologics have been found to reduce symptoms of asthma, improve lung function, reduce the use of oral corticosteroids, and improve quality of life of patients. This article reviews the mechanism of action and indications for approved biologics and discusses what should be considered when choosing biologics.

Citations

Citations to this article as recorded by

Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma
Zeina Kassem, Jenny K. W. Lam, Hanieh Khalili
RSC Pharmaceutics.2026; 3(3): 630. CrossRef
Allergen Immunotherapy for the Prevention and Treatment of Asthma
Thierry Batard, Camille Taillé, Laurent Guilleminault, Andrzej Bozek, Véronique Bordas‐Le Floch, Oliver Pfaar, Walter G. Canonica, Cezmi Akdis, Mohamed H. Shamji, Laurent Mascarell
Clinical & Experimental Allergy.2025; 55(2): 111. CrossRef
Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment
Laura de la Torre-Pérez, Marilina Santero, Wendy Nieto-Gutierrez, Christine Giesen, Angela Nardin, Claudia Cosma, Pedro Silva Pires, Andrea Guida, Marcello Simonini, Camila Quirland Lazo, Feng Xie, Pablo Alonso-Coello
Journal of Clinical Epidemiology.2025; 178: 111621. CrossRef
Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps
Hanna K. Mandl, Jessa E. Miller, Daniel M. Beswick
Otolaryngologic Clinics of North America.2024; 57(2): 225. CrossRef
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
Sara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, Marcela Valverde-Monge, Erwin Javier Pinillos-Robles, Diana Betancor, Mar Fernández-Nieto, Diana Sánchez-Mellado, Marta Gil-Martínez, Jessica Mireya Santillán-Coello, José Miguel Vil
Biomolecules.2024; 14(1): 126. CrossRef
Biologic Therapies across Nasal Polyp Subtypes
Kody G. Bolk, Sarah K. Wise
Journal of Personalized Medicine.2024; 14(4): 432. CrossRef
Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study
Tommaso Pianigiani, Simona Luzzi, Akter Dilroba, Martina Meocci, Elisa Salvadori, Lorenzo Alderighi, Laura Bergantini, Miriana d’Alessandro, Piersante Sestini, Elena Bargagli, Paolo Cameli
Journal of Asthma.2024; 61(12): 1619. CrossRef
Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, Hayeon Noh, Jerome Msihid, You Sook Cho
Allergy, Asthma & Immunology Research.2024; 16(4): 372. CrossRef
Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young, Nathorn Chaiyakunapruk
Journal of Asthma.2023; 60(9): 1702. CrossRef
Tackling the cytokine storm using advanced drug delivery in allergic airway disease
Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar, Gabriele De Rubis, Shakti D. Shukla, Keshav Raj Paudel, Bikash Manandhar, Thakur Gurjeet Singh, Dinesh Kumar Chellappan, Monica Gulati, Indu Pal Kaur, Venkata Sita Rama Raju Allam, Philip M. Hansbro, Brian G.
Journal of Drug Delivery Science and Technology.2023; 82: 104366. CrossRef
The evolving landscape of immunotherapy for the treatment of allergic conditions
Aarti Pandya, Esosa Adah, Bridgette Jones, Rachel Chevalier
Clinical and Translational Science.2023; 16(8): 1294. CrossRef
Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, You Sook Cho
Allergy, Asthma & Immunology Research.2022; 14(2): 182. CrossRef
The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center
Justyna Fijołek, Elzbieta Wiatr, Dorota Piotrowska-Kownacka, Kazimierz Roszkowski-Sliz
Multidisciplinary Respiratory Medicine.2021;[Epub] CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef

Pulmonary and Respiratory Medicine
Therapeutic potential of targeting kinase inhibition in patients with idiopathic pulmonary fibrosis: Suji Kim, Jae Hyang Lim, Chang-Hoon Woo; Yeungnam Univ J Med. 2020;37(4):269-276. Published online July 22, 2020; DOI: https://doi.org/10.12701/yujm.2020.00458

18,787 View
261 Download
6 Crossref

Abstract PDF

Fibrosis is characterized by excessive accumulation of extracellular matrix components. The fibrotic process ultimately leads to organ dysfunction and failure in chronic inflammatory and metabolic diseases such as pulmonary fibrosis, advanced kidney disease, and liver cirrhosis. Idiopathic pulmonary fibrosis (IPF) is a common form of progressive and chronic interstitial lung disease of unknown etiology. Pathophysiologically, the parenchyma of the lung alveoli, interstitium, and capillary endothelium becomes scarred and stiff, which makes breathing difficult because the lungs have to work harder to transfer oxygen and carbon dioxide between the alveolar space and bloodstream. The transforming growth factor beta (TGF-) signaling pathway plays an important role in the pathogenesis of pulmonary fibrosis and scarring of the lung tissue. Recent clinical trials focused on the development of pharmacological agents that either directly or indirectly target kinases for the treatment of IPF. Therefore, to develop therapeutic targets for pulmonary fibrosis, it is essential to understand the key factors involved in the pathogenesis of pulmonary fibrosis and the underlying signaling pathway. The objective of this review is to discuss the role of kinase signaling cascades in the regulation of either TGF--dependent or other signaling pathways, including Rho-associated coiled-coil kinase, c-jun N-terminal kinase, extracellular signal-regulated kinase 5, and p90 ribosomal S6 kinase pathways, and potential therapeutic targets in IPF.

Citations

Citations to this article as recorded by

M2 Macrophage‐Derived TGF‐β1 Drives Tendon Fibrosis in Rodent Tendinopathy Models
Mingyang An, Feng Gao, Baiqing Zhang, Yidong Wu, Kangkang Yu, Zhongyao Li, Yujie Liu, Chunbao Li
Journal of Orthopaedic Research.2026;[Epub] CrossRef
Pulmonary delivery of gene-loaded lipid nanoparticles for targeting TGF-β signaling in idiopathic pulmonary fibrosis
Yashvita Chhabada, Khushwant S. Yadav
Nanomedicine.2026; 21(11): 1671. CrossRef
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Hongbo Ma, Shengming Liu, Shanrui Li, Yong Xia
Frontiers in Pharmacology.2022;[Epub] CrossRef
Vitamin D3 alleviates pulmonary fibrosis by regulating the MAPK pathway via targeting PSAT1 expression in vivo and in vitro
Wenxiang Zhu, Qi Ding, Lu Wang, Gonghao Xu, Yirui Diao, Sihao Qu, Sheng Chen, Yuanyuan Shi
International Immunopharmacology.2021; 101: 108212. CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef
Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report
Alessandro G. Fois, Elisabetta Sotgiu, Valentina Scano, Silvia Negri, Sabrina Mellino, Elisabetta Zinellu, Pietro Pirina, Gianfranco Pintus, Ciriaco Carru, Arduino A. Mangoni, Angelo Zinellu
Antioxidants.2020; 9(11): 1064. CrossRef

Pulmonary and Respiratory Medicine
Diagnosis and treatment of multidrug-resistant tuberculosis: Jong Geol Jang, Jin Hong Chung; Yeungnam Univ J Med. 2020;37(4):277-285. Published online September 4, 2020; DOI: https://doi.org/10.12701/yujm.2020.00626

33,480 View
735 Download
110 Crossref

Abstract PDF

Tuberculosis (TB) is still a major health problem worldwide. Especially, multidrug-resistant TB (MDR-TB), which is defined as TB that shows resistance to both isoniazid and rifampicin, is a barrier in the treatment of TB. Globally, approximately 3.4% of new TB patients and 20% of the patients with a history of previous treatment for TB were diagnosed with MDR-TB. The treatment of MDR-TB requires medications for a long duration (up to 20–24 months) with less effective and toxic second-line drugs and has unfavorable outcomes. However, treatment outcomes are expected to improve due to the introduction of a new agent (bedaquiline), repurposed drugs (linezolid, clofazimine, and cycloserine), and technological advancement in rapid drug sensitivity testing. The World Health Organization (WHO) released a rapid communication in 2018, followed by consolidated guidelines for the treatment of MDR-TB in 2019 based on clinical trials and an individual patient data meta-analysis. In these guidelines, the WHO suggested reclassification of second-line anti-TB drugs and recommended oral treatment regimens that included the new and repurposed agents. The aims of this article are to review the treatment strategies of MDR-TB based on the 2019 WHO guidelines regarding the management of MDR-TB and the diagnostic techniques for detecting resistance, including phenotypic and molecular drug sensitivity tests.

Citations

Citations to this article as recorded by

Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia
Nina Mariana, Anggi Gayatri, Indah Suci Widyahening, Budiman Bela, Neni Sawitri, Soedarsono Soedarsono, Erni Juwita Nelwan, Purwantyastuti Ascobat
International Journal of Risk & Safety in Medicine.2026; 37(2): 235. CrossRef
Mitoxantrone elicits ROS-dependent elimination of dysfunctional mitochondria through mitophagy to control viability of intracellular mycobacteria in human macrophages
Mousumi Das, Dev Kiran Nayak, Salina Patel, Ashish Kumar, Mustafeez Ali Quaderi, Pramathesh Kumar Dandsena, Lincoln Naik, Abtar Mishra, Amit Mishra, Ramandeep Singh, Sujit Kumar Bhutia, Assirbad Behura, Rohan Dhiman
Biochemical Pharmacology.2026; 243: 117512. CrossRef
Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis
Denise M O’Sullivan, Gerwyn M Jones, Manca Zolnir-Dovc, Richard Phillips, Rejoice Arthur, Bariki Mtafya, Daniel Adon Mapamba, Daniela Maria Cirillo, Ewa Augustynowicz-Kopeć, Mei Mei Ho, Belinda Dagg, Sven O Friedrich, Francesca Colavita, Antonella Vulcano
Clinical Chemistry.2026; 72(3): 390. CrossRef
Multipolymeric Oral Ring Formulation of Delamanid: Manufacture, Computer Aided Lead Selection and In vitro Proof of Concept Studies
Saba Abedin, Parnian Noshadravan Angali, Oluwatoyin A. Adeleke
Journal of Pharmaceutical Innovation.2026;[Epub] CrossRef
Decoding antibiotic resistance in tuberculosis: Role of RRDR and non-RRDR mutations in diagnostic perspectives
Risha Hazarika, Sanjukta Patra
Biochemical and Biophysical Research Communications.2026; 812: 153563. CrossRef
Resilience of recombinant antibiotic resistance gene-containing plasmids against common cell culture disposal methods
Austin Gluth, Christian Zmasek, Stephen Chiu, Tae Seok Moon
Cell Reports Methods.2026; 6(6): 101430. CrossRef
Tuberculosis in Pregnancy: An Updated Narrative Review
Carolina Longo, Karina Felippe Monezi Pontes, Marina Matos de Moura Faíco, Mayra Martins Melo, Gustavo Yano Callado, Célio de Barros Barbosa, Edward Araujo Júnior, Antonio Braga
Diagnostics.2026; 16(11): 1576. CrossRef
Aptamer-Loaded Cubosome Lipid Nanoparticles for the Treatment of Tuberculosis
Sampa Sarkar, Tarun Kumar Sharma, Haitao Yu, Brendan Dyett, Andrew S. Ball, Calum J. Drummond, Sarvesh Soni, Charlotte E. Conn
ACS Applied Materials & Interfaces.2026; 18(20): 28511. CrossRef
Design, synthesis and antitubercular evaluation of novel 5,6-diphenyl-1,2,4-triazine-piperazine derivatives targeting mycobacterial dihydrofolate reductase
Uday Thakkar, Moksh Shah, Pratik Khona, Harnisha Patel, Mange Ram Yadav, Salman Patel, Chanchal Singh, Renuka Bhamre, Afzal Nagani
ADMET and DMPK.2026;[Epub] CrossRef
Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management
Siva Bhukya, Ravi Adinarayan Somabattini, Neelanjan Chowdhury, Sathi Sarkar, Anish Kumar Das, Kabita Mahato, Hanumu Korra, Satheesh Kumar Nanjappan
Drug Metabolism Reviews.2026; : 1. CrossRef
Cutting-edge nano novel drug delivery carriers (NDCs) for tuberculosis (TB) management: insights into clinical trials and patent landscape
Rahul Pal, Binita Ghosh, Prottay Dutta, Tapaskumar Mukeshkumar Shah, Akashdeep Singh
Journal of Microencapsulation.2026; 43(3): 251. CrossRef
A Case of Multidrug-Resistant Tuberculosis in an Active Duty Military Health Care Worker
Amanda E Saunders, Kevin M Shanahan, John W Downs
Military Medicine.2025; 190(1-2): e448. CrossRef
Latest Progress on Tuberculosis and HIV Co‐Infection: A Closer Look at People of Different Ages
Anna Yusuf Aliyu, Oluwatoyin A. Adeleke
Advanced Therapeutics.2025;[Epub] CrossRef
Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape
Meghana N. Patel, Archita J. Patel, Manish N. Nandpal, Manan A. Raval, Ravish J. Patel, Amit A. Patel, Keshav Raj Paudel, Philip M. Hansbro, Sachin Kumar Singh, Gaurav Gupta, Kamal Dua, Samir G. Patel
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(3): 2127. CrossRef
The Role of Nanomaterials in Diagnosis and Targeted Drug Delivery
Ekhlakh Veg, Kulsum Hashmi, Saman Raza, Seema Joshi, Abdul Rahman Khan, Tahmeena Khan
Chemistry & Biodiversity.2025;[Epub] CrossRef
Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance
Esteban Zavaleta-Monestel, Carolina Rojas-Chinchilla, Jeimy Campos-Hernández, Ernesto Martínez-Vargas
Cureus.2025;[Epub] CrossRef
Characteristics and treatment outcomes of adolescents and young adults living with HIV with drug-resistant tuberculosis co-infection in Uganda: a retrospective cohort study
Ivaan Pitua, Marvin Kirya, Denis Kiberu, Shivan Nabaasa, Amelia Margaret Namiiro, Michael Collins Segawa, Patrick Semakula, Sarah Maria Najjuka, Joseph Baruch Baluku, Ronald Olum
Therapeutic Advances in Infectious Disease.2025;[Epub] CrossRef
Functional Prognosis of Spinal Cord Injury Due to Spinal Tuberculosis
Farida Arisanti, Tertianto Prabowo, Putri Endyana, Apichana Kovindha
OBM Neurobiology.2025; 09(01): 1. CrossRef
Artemisia Afra and Artemisia Annua against pulmonary tuberculosis
William Wang, Pascal Gisenya
Pharmacy & Pharmacology International Journal.2025; 13(1): 21. CrossRef
Dual Burden of MDR‐TB and COVID‐19 in a Previously Treated Tuberculosis Case: Diagnostic and Therapeutic Dilemmas
Gudisa Bereda
Clinical Case Reports.2025;[Epub] CrossRef
Truenat MTB assays for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
Leeberk Raja Inbaraj, Jefferson Daniel, Mukesh Kumar Sathya Narayanan, Vignes Anand Srinivasalu, Adhin Bhaskar, Katie Scandrett, Priya Rajendran, Richard Kirubakaran, Hemant D Shewade, Muniyandi Malaisamy, Chandrasekaran Padmapriyadarsini, Yemisi Takwoing
Cochrane Database of Systematic Reviews.2025;[Epub] CrossRef
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment
Omobolanle A. Omoteso, Adewale O. Fadaka, Roderick B. Walker, Sandile M. Khamanga
Microorganisms.2025; 13(4): 722. CrossRef
N-Acetylcysteine to Reduce Kidney and Liver Injury Associated with Drug-Resistant Tuberculosis Treatment
Idu Meadows, Happiness Mvungi, Kassim Salim, Oscar Kaswaga, Peter Mbelele, Alphonce Liyoyo, Hadija Semvua, Athumani Ngoma, Scott K. Heysell, Stellah G. Mpagama
Pharmaceutics.2025; 17(4): 516. CrossRef
Head and Neck Tuberculosis: A Rare Diagnosis and the Role of Surgical Biopsy and Histopathological Evaluation in Extrapulmonary Disease
Carmen Aurelia Mogoantă, Andrei Osman, Alina-Maria Georgescu, Alexandra Maria Mitroi, Constantin Ioan Busuioc, Ionuţ Tănase, Ramona Cioboată, Ilona Mihaela Liliac, Ovidiu Lucian Cimpeanu, Mircea Sorin Ciolofan
Pathogens.2025; 14(5): 479. CrossRef
Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management
Wendi Zhou, Hongxu Lu, Jiamin Lin, Jialou Zhu, Jizhen Liang, Yalin Xie, Jinxing Hu, Ning Su
Cancer Reports.2025;[Epub] CrossRef
Green synthesis of Cu nanoparticles using Biarum chaduchrum leaf extract and their efficacy against multi-drug-resistant Mycobacterium tuberculosis
Xiaoguo Zhang, Zaiqin Ling
Chemical Papers.2025; 79(8): 5009. CrossRef
Magnetic nanoparticles as a promising antimicrobial agent for combating multidrug resistant bacteria: a review
Ahmed M. El-Khawaga, Maurizio Orlandini, Luisa Raucci, Karim Elmaghraby
Discover Applied Sciences.2025;[Epub] CrossRef
Education on Assistance for Drug-Resistant TB Patients Since Diagnosis to Community TB Cadres Through Cadre Training Activities in Kediri City in 2025
Nurita Nilasari Bunga Kharisma Arifiana Putri, Heny Kristanto, Yunarsih, Sucipto, Puguh Santoso, Betristasia Puspitasari
Journal of Community Service for Health.2025; 6(1): 026. CrossRef
CRISPR-Cas9-based electrochemical biosensor for the detection of katG gene mutations in isoniazid-resistant tuberculosis
Dika Apriliana Wulandari, Muhammad Ihda Hamlu Liwaissunati Zein, Salma Nur Zakiyyah, Safri Ishmayana, Mehmet Ozsoz, Yeni Wahyuni Hartati, Irkham
ADMET and DMPK.2025; : 2766. CrossRef
Characterizing Musculoskeletal and Neurological Toxicities Associated With the BPaLM Regimen: A Clinical Evaluation of Arthralgia and Peripheral Neuropathy in Patients With Multidrug-Resistant Tuberculosis (MDR-TB)
Zahir Khan, Gohar Ali, Rumman ., Ashraf ., Akmal Naveed, Shahid Salam, Ubaid Ullah, Ahmad Ismail, Afrasyab Altaf
Cureus.2025;[Epub] CrossRef
A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis Management
Mohammed Alfaqeeh, Prayudi Santoso, Jan-Willem Alffenaar, Ivan Pradipta
Journal of Multidisciplinary Healthcare.2025; Volume 18: 3531. CrossRef
Role of Transcription Factor NR1H3 in the Pathogenesis of Tuberculosis
Anju Kumari, Rajwinder Kaur
Biology Bulletin Reviews.2025; 15(4): 475. CrossRef
Pre-treatment loss to follow-up and associated factors among drug-resistant tuberculosis patients diagnosed in Wakiso district, central Uganda
James Arinaitwe, James Muleme, Perez N. Ochanda, Rebecca Nuwematsiko, Samson Omongot, Barnabas Bakamutumaho, Esther Buregyeya
BMC Infectious Diseases.2025;[Epub] CrossRef
Drug selection based on pan-genomics genetic features of Mycobacterium tuberculosis
Xiangcheng Sun, Panpan Xu, Yun Shi, Ning Wang, Yan Li
Frontiers in Microbiology.2025;[Epub] CrossRef
All‐Oral Shorter Treatment Regimens for Multidrug‐ and Rifampicin‐Resistant Tuberculosis: Evaluating Their Effectiveness, Safety, and Impact on the Quality of Life of Patients in Lao PDR
Vibol Iem, Sakhone Suthepmany, Vongkham Inthavong, Anousone Sisouvanh, Khamloun Choumlivong, Kyung Hyun Oh, Philipp du Cros, Fatimata Bintou Sall, Corinne S. Merle, Jacques Sebert, Donekham Inthavong
Tropical Medicine & International Health.2025; 30(12): 1340. CrossRef
Diagnostic assistance method for RR-TB/MDR-TB patients under treatment based on CNN-LSTM
Jie Li, Wenqing Wu, Zhixiong Fang, Pinxiang Fu, Hua Huang, Yanhong Zhou, Liang Yu, He Huang, Tao Wang, Qilong Zhang
Scientific Reports.2025;[Epub] CrossRef
Label-free electrochemical-based biosensor for gene-phosphatidylinositol mannosides detection in urine for the determination of multidrug-resistant tuberculosis
Dinesh R Rotake, Jitendra B Zalke, Arpita Parakh, Shubham C Anjankar, Shiv Govind Singh, Ranjana Singh
Nanotechnology.2025; 36(41): 415501. CrossRef
Immune profiles of immune checkpoint molecules on peripheral T cells in multidrug resistant-tuberculosis
Xiaoxu Yang, Lan Yao, Xu-wei Gui, Yangdian Lai, Ping Ji, Ying Wang, Yingying Chen, Wei Sha
International Journal of Infectious Diseases.2025; 161: 108085. CrossRef
Magnitude of poor multidrug-resistant tuberculosis treatment outcome among multidrug-resistant tuberculous patients at tertiary hospital, South West Ethiopia
Gemechu Gelana Ararame, Hailegabreil Nardos
Annals of Clinical Microbiology and Antimicrobials.2025;[Epub] CrossRef
Predicting multi-drug resistant tuberculosis using machine learning on genomic and clinical data
Komal Saxena, S Shyni Carmel Mary, Prolay Ghosh, Chinnem Rama Mohan, Mohd Naved, Mukesh Madanan
Indian Journal of Tuberculosis.2025; 72: S99. CrossRef
Comparative genomic analysis of drug-resistant and drug-sensitive tuberculosis strains and their impact on cough severity
Malik Olatunde Oduoye, Hiba Zafar, Umer Wamiq, Suheera Afzoon, Hafsa Shuja, Adeniji Oluwapelumi Wumi, Abdulmumeen Ibrahim Opeyemi
Mycobacteria.2025;[Epub] CrossRef
Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis
Siti Soidah, Toto Subroto, Irvan Faizal, Muhammad Yusuf
Pathogens.2025; 15(1): 16. CrossRef
Optimal accompanying diagnosis design through external validation of population pharmacokinetic models for moxifloxacin in tuberculosis patients
Hyunjung Lee, Woojin Jung, Min Jung Chang, Soyoung Lee, Jung-woo Chae, Radojka M. Savic, Hwi-yeol Yun
BMC Infectious Diseases.2025;[Epub] CrossRef
The Relationship Between Family Social Support and Medication Adherence Among Tuberculosis Patients in Community Health Centers of Sleman Regency
Kusbandia M.Pharm, Anna Wahyuni Widayanti, Chairun Wiedyaningsih
Malaysian Journal of Medicine and Health Sciences.2025;[Epub] CrossRef
The prevalence of multidrug-resistant Mycobacterium tuberculosis in patients diagnosed with pulmonary TB at Ngwelezana Hospital. A quantitative cross-sectional retrospective.
Nonduduzo Magubane, Simangaliso Shangase
Student's Journal of Health Research Africa.2025; 6(9): 14. CrossRef
Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening study
Manikandan Jayaraman, Vijayakumar Gosu, Rajalakshmi Kumar, Jeyakanthan Jeyaraman
Computational Biology and Chemistry.2024; 108: 107991. CrossRef
Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors**
Waseem Ali, Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Rahul Sharma, Meetu Agarwal, Javaid Ahmad Sheikh, Abhinav Grover, Sonam Grover
Molecular Informatics.2024;[Epub] CrossRef
A Comprehensive Review on Long vs. Short Regimens in Multidrug-Resistant Tuberculosis (MDR-TB) Under Programmatic Management of Drug-Resistant Tuberculosis (PMDT)
Ashwin Karnan, Ulhas Jadhav, Babaji Ghewade, Anjana Ledwani, Poorna Shivashankar
Cureus.2024;[Epub] CrossRef
Design, synthesis and biological evaluation of novel pyrido-[2,3-d]-pyrimidin-2-amine analogues as antimycobacterial agents
Boddupalli Venkata Siva Kumar, Yogesh Mahadu Khetmalis, Kosana Sai Chaitanya, Ala Chandu, Gauri Shetye, Rui Ma, Sankaranarayanan Murugesan, Scott G. Franzblau, Kondapalli Venkata Gowri Chandra Sekhar
Journal of Molecular Structure.2024; 1303: 137600. CrossRef
Direct TAMRA-dUTP labeling of M. tuberculosis genes using loop-mediated isothermal amplification (LAMP)
Basma Altattan, Jasmin Ullrich, Emily Mattig, Aline Poppe, Renata Martins, Frank F. Bier
Scientific Reports.2024;[Epub] CrossRef
Antimicrobial peptides as new-generation antibiotics against Mycobacterium
Parisa Eslami, Adnan Khosravi
Journal of Preventive, Diagnostic and Treatment Strategies in Medicine.2024; 3(1): 6. CrossRef
Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study
Kunhe Lin, Li Xiang
Risk Management and Healthcare Policy.2024; Volume 17: 727. CrossRef
Development of a self-microemulsifying drug delivery system to deliver delamanid via a pressurized metered dose inhaler for treatment of multi-drug resistant pulmonary tuberculosis
Himanshu Paliwal, Titpawan Nakpheng, Pijush Kumar Paul, K. Prem Ananth, Teerapol Srichana
International Journal of Pharmaceutics.2024; 655: 124031. CrossRef
Drug Targets, Current and Future Therapeutics for the Treatment of Multi Drug Resistant Tuberculosis with their Clinical Applications: A Critical Review
Deepshikha Singh, Vikram Singh, Subhankar P. Mandal, Karen Dsouza, B.R. Prashantha Kumar, Sheshagiri R. Dixit
Current Drug Therapy.2024; 19(3): 317. CrossRef
Epidemiology and Management of Infections in Liver Transplant Recipients
Waseem Amjad, Syed Hamaad Rahman, Thomas D. Schiano, Syed-Mohammed Jafri
Surgical Infections.2024; 25(4): 272. CrossRef
Survival Probability in Multidrug Resistant Pulmonary Tuberculosis Patients in a South Indian Region
Thungathurthi Smitha, Pantham Sunitha, Orsu Prabhakar, Sindgi Vasudeva Murthy
Hospital Pharmacy.2024; 59(4): 427. CrossRef
Tuberculosis: Implications for Dentistry
Xue-Mei Chong, Lucy McClean, Paddy McMaster
Dental Update.2024; 51(4): 258. CrossRef
The mechanisms and clinical potential of collateral sensitivity in Mycobacterium tuberculosis: A literature review
Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Musab Maqsood, Muhammad Hashim Faisal
The Microbe.2024; 3: 100086. CrossRef
Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis
Govinda Raju Vadankula, Vipul V. Nilkanth, Arshad Rizvi, Sriram Yandrapally, Anushka Agarwal, Hepshibha Chirra, Rashmita Biswas, Mohammed Arifuddin, Vijay Nema, Alvala Mallika, Shekhar C. Mande, Sharmistha Banerjee
ACS Infectious Diseases.2024; 10(6): 2288. CrossRef
Advancements in Artificial Intelligence for the Diagnosis of Multidrug Resistance and Extensively Drug-Resistant Tuberculosis: A Comprehensive Review
Shanmuga Priya K, Anbumaran Parivakkam mani, Geethalakshmi S, Sankalp Yadav
Cureus.2024;[Epub] CrossRef
Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control
Isaac Darko Otchere, Adwoa Asante-Poku, Kodjo Francis Akpadja, Awa Ba Diallo, Adama Sanou, Prince Asare, Stephen Osei-Wusu, Nneka Onyejepu, Bassirou Diarra, Yaotsè Anoumou Dagnra, Aderemi Kehinde, Martin Antonio, Dorothy Yeboah-Manu
Frontiers in Public Health.2024;[Epub] CrossRef
Advanced integrative molecular platform for high-throughput screening of drug-resistant tuberculosis
Minal Dakhave, Trupti Rale, Harshada Suryawanshi, Nikita Patil, Abhijeet Suryawanshi, Raju Kumar, Shruti Gadekar, Payal Bhatnagar, Amrita Khaire, Gautam Wankhede
Diagnostic Microbiology and Infectious Disease.2024; 109(4): 116373. CrossRef
The use of additive technologies to increase adherence to treatment, increase the efficiency of chemotherapy and correction of indicators of anxiety and depression among patients with destructive pulmonary tuberculosis
Alexey G. Naumov, Alexander S. Shprykov, Marina A. Dolgova, Natalia V. Fomina
Consilium Medicum.2024; 26(3): 199. CrossRef
Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis
Cong Jin, Yuting Wu, Jiangpo Chen, Jing Liu, Hongwei Zhang, Qingzeng Qian, Tieliang Pang
Journal of Global Antimicrobial Resistance.2024; 38: 292. CrossRef
Enhanced detection of rifampicin and isoniazid resistance in mycobacterium tuberculosis using AuNP-qPCR: a rapid and accurate method
Mouhai He
American Journal of Translational Research.2024; 16(6): 2310. CrossRef
Identification of tuberculosis inhibitors through QSAR-based virtual screening and molecular dynamics simulation of novel pyrimidine derivatives
Abdelmadjid Guendouzi, Lotfi Belkhiri, Yaakoub Kebila, Brahim Houari, Abdelhamid Djekoune, Abdou Boucekkine, Jehad Zuhair Tayyeb, Shopnil Akash, Magda H. Abdellattif, Abdelkrim Guendouzi
Journal of the Indian Chemical Society.2024; 101(10): 101298. CrossRef
Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis
Guneswar Sethi, Rinku Polachirakkal Varghese, Avinash Kant Lakra, Subhashree Subhasmita Nayak, Ramadas Krishna, Jeong Ho Hwang
Scientific Reports.2024;[Epub] CrossRef
Optimization of Polylactide-Co-Glycolide-Rifampicin Nanoparticle Synthesis, In Vitro Study of Mucoadhesion and Drug Release
Nazgul A. Yessentayeva, Aldana R. Galiyeva, Arailym T. Daribay, Daniyar T. Sadyrbekov, Rouslan I. Moustafine, Yerkeblan M. Tazhbayev
Polymers.2024; 16(17): 2466. CrossRef
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis
Nazanin Ahmad Khosravi, Mehrandokht Sirous, Azar Dokht Khosravi, Morteza Saki
Journal of Clinical Laboratory Analysis.2024;[Epub] CrossRef
A review of molecular investigations on traditional Chinese medicinal plant-based therapies in multidrug-resistant tuberculosis
Robin Raj, Arpan Kumar Tripathi, P. Saranya, Jaskiran kaur, Rashmi Saxena Pal, Kuldeep Singh, Divya Jain, MVNL Chaitanya, Shivendra Kumar
Pharmacological Research - Modern Chinese Medicine.2024; 13: 100521. CrossRef
Multidrug-resistant tuberculosis treatment outcomes and associated factors at Yirgalem General Hospital, Sidama Region, South Ethiopia: a retrospective cohort study
Assefa Hamato Kebede, Hassen Mamo
BMC Pulmonary Medicine.2024;[Epub] CrossRef
Prediction of the Potential of Benzoxazinone, 2-phenyl-4H-benzo[1,3]oxazin-4-one, and 2-[2-(4-methoxyphenyl)vinyl]-3,1-benzoxazin-4-one as New Anti-Tuberculosis
Kholis Amalia Nofianti, Luqmanul Hakim, Suzana, Farida Ifadotunikamah
Berkala Ilmiah Kimia Farmasi.2024; 11(1): 26. CrossRef
Comparison of Anxiety Levels in MDR-TB Patients with Individual and Short-term Regimens at Dr. Soebandi Regional General Hospital, Jember, Indonesia
Muhammad Rifqy Alvy Widodo, Ida Srisurani Wiji Astuti, Inke Kusumastuti, Angga Mardro Raharjo, Supangat Supangat, Justina Evy Tyaswati, Noor Fadzilah binti Zulkifli
Jurnal Respirasi.2024; 10(2): 107. CrossRef
Novel Prodrug Strategies for the Treatment of Tuberculosis
Christine G. Kim, Jiney Jose, Michael P. Hay, Peter J. Choi
Chemistry – An Asian Journal.2024;[Epub] CrossRef
Advances in the Synthesis and Biological Applications of Enoxacin-Based Compounds
Garba Suleiman, Nabil El Brahmi, Gérald Guillaumet, Saïd El Kazzouli
Biomolecules.2024; 14(11): 1419. CrossRef
Treatment outcomes in patients with multi-drug resistant tuberculosis
Unyime Israel Eshiet, Mary Richard Akpan, Idongesit Linus Jackson, Aniekpeno Sunday Uduak, Dighenyong Samuel Udiminue
Medicine India.2024; 3: 77. CrossRef
Molecular genetic characteristics of Mycobacterium tuberculosis strains isolated from newly identified tuberculosis patients in the Republic of Azerbaijan
Nuria Salimova, Dmitry Gryadunov
Bulletin of the Academy of Sciences of Moldova. Medical Sciences.2024; 79(2): 30. CrossRef
Synthesis and Structure–Activity Relationship of 2,6-Disubstituted Thiosemicarbazone Derivatives of Pyridine as Potential Antituberculosis Agents
Dagmara Ziembicka, Katarzyna Gobis, Małgorzata Szczesio, Andrzej Olczak, Ewa Augustynowicz-Kopeć, Agnieszka Głogowska, Izabela Korona-Głowniak, Krzysztof Bojanowski
Materials.2023; 16(1): 448. CrossRef
Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
Kona Chowdhury, Rahnuma Ahmad, Susmita Sinha, Siddhartha Dutta, Mainul Haque
Cureus.2023;[Epub] CrossRef
Anxiety and depression level of patients with multidrug-resistant tuberculosis (MDR-TB) in two hospitals in Banten province, Indonesia
Tirta Darmawan Susanto, Allen Widysanto, Darien Alfa Cipta, Arron Tanara, Ghivarell Rizkie Wirawan, Adeline Bercadina Kosim, Christabella Maria Djoni, Ervinna Tantri, Chandni Kumar, Chelsie Angelius
Dialogues in Health.2023; 2: 100115. CrossRef
Characteristics of Previous Tuberculosis Treatment History in Patients with Treatment Failure and the Impact on Acquired Drug-Resistant Tuberculosis
Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Wiwik Kurnia Ilahi, Amelia Tantri Anggraeni
Antibiotics.2023; 12(3): 598. CrossRef
Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnostics
Srestha Mukherjee, Summaya Perveen, Anjali Negi, Rashmi Sharma
Tuberculosis.2023; 140: 102340. CrossRef
Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
Sakshi Patel, Malti Dadheech, Anand K Maurya, Jitendra Singh, Shashank Purwar, Nirendra Rai, Radha Sarawagi, Ankur Joshi, Sagar Khadanga
Cureus.2023;[Epub] CrossRef
Tandem LC-MS Identification of Antitubercular Compounds in Zones of Growth Inhibition Produced by South African Filamentous Actinobacteria
Daniel J. Watson, Lubbe Wiesner, Tlhalefo Matimela, Denzil Beukes, Paul R. Meyers
Molecules.2023; 28(11): 4276. CrossRef
Drug-Resistant Tuberculosis Stigma Among HealthCare Workers Toward the Development of a Stigma-Reduction Strategy: A Scoping Review
Lolita Liboon Aranas, Khorshed Alam, Prajwal Gyawali, Rashidul Mahumud Alam
INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2023;[Epub] CrossRef
Quality Mindset: The Missing Ingredient in Tuberculosis Care and Control in Togo
Kossivi Agbélénko Afanvi, Mohammed Fall Dogo, Koffi Atsu Aziagbé, Komi Séraphin Adjoh, Koumavi Kristoli Didier Ekouévi
European Journal of Theoretical and Applied Sciences.2023; 1(4): 36. CrossRef
Machine Learning of the Whole Genome Sequence of Mycobacterium tuberculosis: A Scoping PRISMA-Based Review
Ricardo Perea-Jacobo, Guillermo René Paredes-Gutiérrez, Miguel Ángel Guerrero-Chevannier, Dora-Luz Flores, Raquel Muñiz-Salazar
Microorganisms.2023; 11(8): 1872. CrossRef
Cotreatment With Clofazimine and Rapamycin Eliminates Drug-Resistant Tuberculosis by Inducing Polyfunctional Central Memory T-Cell Responses
Dhiraj Kumar Singh, Ashima Bhaskar, Isha Pahuja, Aishwarya Shaji, Barnani Moitra, Yufang Shi, Ved Prakash Dwivedi, Gobardhan Das
The Journal of Infectious Diseases.2023; 228(9): 1166. CrossRef
Treatment of drug-resistant tuberculosis in children and young adolescents in Brazil
Fernanda Bruzadelli Paulino da Costa, Thaís Zamboni Berra, Jaqueline Garcia de Almeida Ballestero, Patricia Bartholomay Oliveira, Daniele Maria Pelissari, Yan Mathias Alves, Antônio Carlos Vieira Ramos, Juliana Queiroz Rocha de Paiva, Titilade Kehinde Aya
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2023; 33: 100388. CrossRef
Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis
Giuseppe Mancuso, Angelina Midiri, Silvia De Gaetano, Elena Ponzo, Carmelo Biondo
Microorganisms.2023; 11(9): 2277. CrossRef
Drug-resistant Monoarticular Wrist Joint Tuberculosis in Renal Transplant Recipient with Literature Review
Jasmine Sethi, Vignesh Subramani, Rajender Kumar, Shivakumar Patil, Ashish Sharma
Indian Journal of Transplantation.2023; 17(3): 371. CrossRef
Predictive capabilities of baseline radiological findings for early and late disease outcomes within sensitive and multi-drug resistant tuberculosis cases
Gabriel Rosenfeld, Andrei Gabrielian, Darrell Hurt, Alex Rosenthal
European Journal of Radiology Open.2023; 11: 100518. CrossRef
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
Mahesh Kumar, Tarun Virmani, Girish Kumar, Rohitas Deshmukh, Ashwani Sharma, Sofia Duarte, Pedro Brandão, Pedro Fonte
Pharmaceuticals.2023; 16(10): 1360. CrossRef
A systematic review and meta-analysis on the correlation between HIV infection and multidrug-resistance tuberculosis
Yulong Song, Qian Jin, Jihai Qiu, Dan Ye
Heliyon.2023; 9(11): e21956. CrossRef
Current Insights into Diagnosing and Treating Neurotuberculosis in Adults
Sofiati Dian, Ahmad Rizal Ganiem, Lindsey HM te Brake, Arjan van Laarhoven
CNS Drugs.2023; 37(11): 957. CrossRef
Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis
Temesgen Yihunie Akalu, Archie C. A. Clements, Haileab Fekadu Wolde, Kefyalew Addis Alene
Scientific Reports.2023;[Epub] CrossRef
Nano vs Resistant Tuberculosis: Taking the Lung Route
Deepika Sharma, Pooja, Sunita Nirban, Smriti Ojha, Tarun Kumar, Neha Jain, Najwa Mohamad, Pradeep Kumar, Manisha Pandey
AAPS PharmSciTech.2023;[Epub] CrossRef
Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review
Deepak Vishwakarma, Abhay Gaidhane, Sweta Sahu, Ashwini S Rathod
Cureus.2023;[Epub] CrossRef
Multidrug-resistant Tuberculosis and its Implication with COVID-19
Jasmine Arya, Sweety Dahiya, Anil Kumar Chhillar
Coronaviruses.2023;[Epub] CrossRef
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance
Summaya Perveen, Diksha Kumari, Kuljit Singh, Rashmi Sharma
European Journal of Medicinal Chemistry.2022; 229: 114066. CrossRef
Abdominal Tuberculosis Mimicking Ovarian Cancer: A Case Report and Review of the Literature
Ikhwan Rinaldi, Abdul Muthalib, Djaja Gosal, Teguh Wijayadi, Barlian Sutedja, Tjondro Setiawan, Andika Gunawan, Nelly Susanto, Lingga Magdalena, Diah Rini Handjari, Fetisari Kurniawan, Aisyah Rifani, Kevin Winston
International Medical Case Reports Journal.2022; Volume 15: 169. CrossRef
Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?
Lehlogonolo N. F. Maphalle, Bozena B. Michniak-Kohn, Modupe O. Ogunrombi, Oluwatoyin A. Adeleke
Children.2022; 9(8): 1120. CrossRef
Various approaches to improving adherence of patients with tuberculosis. Prospects for the use of additive technologies in TB practice
A. G. Naumov, A. S. Shprykov
PULMONOLOGIYA.2022; 34(1): 80. CrossRef
Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review
Gabriel S. Oliveira, Raquel P. Costa, Paula Gomes, Maria Salomé Gomes, Tânia Silva, Cátia Teixeira
Pharmaceuticals.2021; 14(4): 323. CrossRef
Treatment of Human Babesiosis: Then and Now
Isaline Renard, Choukri Ben Mamoun
Pathogens.2021; 10(9): 1120. CrossRef
Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand
Ei Phoo Thwe, Wises Namwat, Porntip Pinlaor, Kulrattana Rueangsak, Arunnee Sangka
World Journal of Microbiology and Biotechnology.2021;[Epub] CrossRef
On the Mechanism of Development of Autoimmune Diseases Following Exposure to Inactivated Mycobacterium tuberculosis
SV Skupnevskiy, GM Trukhina, EG Pukhaeva, AK Badtiev, FK Rurua, FE Batagova, ZhG Farnieva
ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT.2021; : 76. CrossRef
Oral regimen for multi-drug-resistant TB can promote patient-centred and community-based treatment
Suman Saurabh, Pankaj Bhardwaj
Journal of Family Medicine and Primary Care.2021; 10(12): 4607. CrossRef
Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis
Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc, Elena Cătălina Lupușoru
Pneumologia.2021; 70(3): 117. CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef

Pulmonary and Respiratory Medicine
Novel respiratory infectious diseases in Korea: Hyun Jung Kim; Yeungnam Univ J Med. 2020;37(4):286-295. Published online September 23, 2020; DOI: https://doi.org/10.12701/yujm.2020.00633

12,553 View
82 Download
6 Crossref

Abstract PDF

Respiratory infections are very common and highly contagious. Respiratory infectious diseases affect not only the person infected but also the family members and the society. As medical sciences advance, several diseases have been conquered; however, the impact of novel infectious diseases on the society is enormous. As the clinical presentation of respiratory infections is similar regardless of the pathogen, the causative agent is not distinguishable by symptoms alone. Moreover, it is difficult to develop a cure because of the various viral mutations. Various respiratory infectious diseases ranging from influenza, which threaten the health of mankind globally, to the coronavirus disease 2019, which resulted in a pandemic, exist. Contrary to human expectations that development in health care and improvement in hygiene will conquer infectious diseases, humankind’s health and social systems are threatened by novel infectious diseases. Owing to the development of transport and trading activity, the rate of spread of new infectious diseases is increasing. As respiratory infections can threaten the members of the global community at any time, investigations on preventing the transmission of these diseases as well as development of effective antivirals and vaccines are of utmost importance and require a worldwide effort.

Citations

Citations to this article as recorded by

Acute respiratory infection (COVID-19) risk prediction in travelers: A random forest model
Jingbo Yu, Hao Yu, Yuming Wang, Qiang Zeng
Infectious Disease Modelling.2026; 11(3): 947. CrossRef
Evaluation and analysis of respiratory infectious disease prevention behaviors in older adults
Liliang Yu, Min Liu, Qing Tan, Dan Wang, Xiaoyun Chen, Mingming Zhao, Jiang Long, Mingyue Fan, Daikun Zheng
Frontiers in Public Health.2024;[Epub] CrossRef
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis
Tácito Zaildo, Thayla Amorim Santino, Gabriela Chaves, Baldomero Antonio Kato da Silva, João Carlos Alchieri, Cecilia M. Patino, Sarah Leite, Kleber Giovanni Luz, Ricardo Oliveira Guerra, Tito Hugo Soares da Penha, Gabriel Rodrigues da Silva, Ada Cristina
European Respiratory Review.2023; 32(168): 220238. CrossRef
Diarylpentanoids, the privileged scaffolds in antimalarial and anti‐infectives drug discovery: A review
Amirah H. Ramli, Siti M. Mohd Faudzi
Archiv der Pharmazie.2023;[Epub] CrossRef
Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea
Da Hae Kim, Thi Mai Nguyen, Jin Hee Kim
International Journal of Environmental Research and Public Health.2021; 18(11): 6008. CrossRef
Advances in the science and treatment of respiratory diseases
Jin Hong Chung
Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef

Review article

Urology
Frailty and elderly in urology: implications for postoperative complications: Phil Hyun Song; Yeungnam Univ J Med. 2020;37(4):296-301. Published online October 8, 2020; DOI: https://doi.org/10.12701/yujm.2020.00752

8,579 View
76 Download
1 Crossref

Abstract PDF

The geriatric population is at a greater risk of postoperative complications than young adults. This risk is associated with the physiologic decline seen in this population known as frailty. Unlike fitter patients, frail patients who undergo operative treatment have a greater likelihood of developing postoperative complications and endure prolonged hospital stays. This circumstance is comparable to the urological status. Therefore, tolerable measurement of frailty as a domain of preoperative health status has been suggested to ascertain vulnerability in elderly patients. In this review, we will elaborate on the concept of frailty and examine its importance with respect to surgical complications, focusing on the urological status.

Citations

Citations to this article as recorded by

Frailty and surgical outcomes in genitourinary prosthetic procedures: an ACS-NSQIP comparative analysis of risk indices
Umar Ghaffar, Behzad Abbasi, Nizar Hakam, Adrian Fernandez, Marvin N. Carlisle, Robert Pearce, Hiren V. Patel, Kevin D. Li, Nikit Venishetty, Benjamin N. Breyer
International Urology and Nephrology.2025; 57(9): 2885. CrossRef

Original articles

Surgery
Usefulness of intraoperative determination of central lymph node metastasis by palpation in papillary thyroid cancer: Wan Wook Kim, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Won Hwa Kim, Hye Jung Kim, Ji-Young Park, Ralph P. Tufano; Yeungnam Univ J Med. 2020;37(4):302-307. Published online April 22, 2020; DOI: https://doi.org/10.12701/yujm.2020.00122

9,013 View
79 Download
1 Crossref

Abstract PDF

Background
This study evaluated the usefulness of judgment of central lymph node (LN) metastasis by surgeon’s palpation in papillary thyroid cancer.
Methods
This study included 127 patients who underwent thyroidectomy and central compartment node dissection between October 2014 and February 2015. The criterion for suspicious LNs was hardness.
Results
Of the 20.5% (28/127) of suspicious for metastatic LNs according to surgeon determination, 92.8% (26/28) were confirmed to be metastatic in the final pathological examinations. Metastatic LNs were found in 38 (38.3%) of 99 patients without suspicious LNs, 29 of whom (76.3%) had micrometastases. The sensitivity, specificity, and positive and negative predictive values for the determination of LN metastasis by a surgeon were 40.6%, 96.8%, 92.9%, and 61.6%, respectively.
Conclusion
Determination of central LN metastasis by a surgeon’s palpation may be useful to evaluate LNs owing to the high specificity and positive predictive values, especially in macrometastasis or high-risk LN disease.

Citations

Citations to this article as recorded by

Impedance-based detection of cervical lymph-node involvement in thyroid cancer patients: a human model study
Hossein Ataee, Mohammad Seraj, Reihane Mahdavi, Ali Fardoost, Abdollah Shafiee, Khosro Shamsi, Mohammadreza Fattahi, Hojat Ebrahiminik, Parisa Hoseinpour, Shahram Sane, Mehran Ghazimoghaddam, Mohammad Esmaeel Akbari, Mohammad Abdolahad
Surgery Today.2025; 55(10): 1497. CrossRef

Obstetrics, Gynecology, and Reproductive Medicine
Clinical outcomes of hysterectomy for benign diseases in the female genital tract: 6 years’ experience in a single institute: Hyo-Shin Kim, Yu-Jin Koo, Dae-Hyung Lee; Yeungnam Univ J Med. 2020;37(4):308-313. Published online April 24, 2020; DOI: https://doi.org/10.12701/yujm.2020.00185

10,176 View
202 Download
2 Crossref

Abstract PDF

Background
Hysterectomy is one of the major gynecologic surgeries. Historically, several surgical procedures have been used for hysterectomy. The present study aims to evaluate the surgical trends and clinical outcomes of hysterectomy performed for benign diseases at the Yeungnam University Hospital.
Methods
We retrospectively reviewed patients who underwent a hysterectomy for benign diseases from 2013 to 2018. Data included the patients’ demographic characteristics, surgical indications, hysterectomy procedures, postoperative pathologies, and perioperative outcomes.
Results
A total of 809 patients were included. The three major indications for hysterectomy were uterine leiomyoma, pelvic organ prolapse, and adenomyosis. The most common procedure was total laparoscopic hysterectomy (TLH, 45.2%), followed by open hysterectomy (32.6%). During the study period, the rate of open hysterectomy was nearly constant (29.4%–38.1%). The mean operative time was the shortest in the single-port laparoscopic assisted vaginal hysterectomy (LAVH, 89.5 minutes), followed by vaginal hysterectomy (VH, 96.8 minutes) and TLH (105 minutes). The mean decrease in postoperative hemoglobin level was minimum in single-port LAVH (1.8 g/dL) and VH (1.8 g/dL). Conversion to open surgery or multi-port surgery occurred in five cases (0.6%). Surgical complications including wound dehiscence, organ injuries, and conditions requiring reoperation were observed in 52 cases (6.4%).
Conclusion
Minimally invasive approach was used for most hysterectomies for benign diseases, but the rate of open hysterectomy has mostly remained constant. Single-port LAVH and VH showed the most tolerable outcomes in terms of operative time and postoperative drop in hemoglobin level in selected cases.

Citations

Citations to this article as recorded by

Depression and qulity of life in women of reproductive age in the context of surgical menopause
Olga Cernetchi, Elena Vataman
Bulletin of the Academy of Sciences of Moldova. Medical Sciences.2025; (2(82)): 18. CrossRef
Analysis of Different Routes of Hysterectomy Based on a Prospective Algorithm and Their Complications in a Tertiary Care Institute
Subrat Panda, Ananya Das, Rituparna Das, Nalini Sharma, Wansalan Shullai, Vinayak Jante, Anusuya Sharma, Kaushiki Singh, Prateeti Baruah, Ruksana Makakmayum, Imtiaz Wani
Minimally Invasive Surgery.2022; 2022: 1. CrossRef

Endocrinology, Diabetes, and Metabolism
Risk factors affecting amputation in diabetic foot: Jun Ho Lee, Ji Sung Yoon, Hyoung Woo Lee, Kyu Chang Won, Jun Sung Moon, Seung Min Chung, Yin Young Lee; Yeungnam Univ J Med. 2020;37(4):314-320. Published online May 6, 2020; DOI: https://doi.org/10.12701/yujm.2020.00129

12,521 View
261 Download
20 Crossref

Abstract PDF

Background
A diabetic foot is the most common cause of non-traumatic lower extremity amputations (LEA). The study seeks to assess the risk factors of amputation in patients with diabetic foot ulcers (DFU).
Methods
The study was conducted on 351 patients with DFUs from January 2010 to December 2018. Their demographic characteristics, disease history, laboratory data, ankle-brachial index, Wagner classification, osteomyelitis, sarcopenia index, and ulcer sizes were considered as variables to predict outcome. A chi-square test and multivariate logistic regression analysis were performed to test the relationship of the data gathered. Additionally, the subjects were divided into two groups based on their amputation surgery.
Results
Out of the 351 subjects, 170 required LEA. The mean age of the subjects was 61 years and the mean duration of diabetes was 15 years; there was no significant difference between the two groups in terms of these averages. Osteomyelitis (hazard ratio [HR], 6.164; 95% confidence interval [CI], 3.561−10.671), lesion on percutaneous transluminal angioplasty (HR, 2.494; 95% CI, 1.087−5.721), estimated glomerular filtration rate (eGFR; HR, 0.99; 95% CI, 0.981−0.999), ulcer size (HR, 1.247; 95% CI, 1.107−1.405), and forefoot ulcer location (HR, 2.475; 95% CI, 0.224−0.73) were associated with risk of amputation.
Conclusion
Osteomyelitis, peripheral artery disease, chronic kidney disease, ulcer size, and forefoot ulcer location were risk factors for amputation in diabetic foot patients. Further investigation would contribute to the establishment of a diabetic foot risk stratification system for Koreans, allowing for optimal individualized treatment.

Citations

Citations to this article as recorded by

Hemoglobin-albumin-lymphocyte-platelet score associated with diabetic foot severity, unlike modified systemic immune-inflammatory index and modified systemic inflammatory response index
Weiyu Pan, Zhaoyuan Nie, Qizhi Tang, Ling Zhao
Frontiers in Endocrinology.2026;[Epub] CrossRef
Sarcopenia Influences Clinical Outcome in Hospitalized Patients with Peripheral Artery Disease Aged 75 Years and Older
Volker H. Schmitt, Lukas Hobohm, Christoph Brochhausen, Christine Espinola-Klein, Philipp Lurz, Thomas Münzel, Omar Hahad, Karsten Keller
Annals of Vascular Surgery.2025; 110: 54. CrossRef
THE PREVALENCE OF ANISOMELIA AND NEUROSENSORY IMPAIRMENT AS RISK FACTORS FOR TROPHIC ULCER FORMATION IN DIABETIC PATIENTS
Anna Ivanova, Oksana Melekhovets
Eastern Ukrainian Medical Journal.2025; 13(1): 130. CrossRef
A comprehensive approach to diabetic foot ulcers treatment in patients with anisomelia
A.S. Ivanova, O.K. Melekhovets, I.V. Melekhovets
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(2): 140. CrossRef
Risk Factors for Amputation Among Patients with Diabetic Foot Disease in a Tertiary Hospital
Anna Colleen Rossi, Francis Pekdasen Solang, Isagani Garin
Philippine Journal of Orthopaedics.2025; 40(3): 36. CrossRef
Efficacy of Chinese and Western Medical Techniques in Treating Diabetic Foot Ulcers With Necrotizing Fasciitis of the Lower Leg
Yongchong Chen, Yunzhu Wang, TaiAn Zhang, Chao Meng, Qing Li, Bohui Zhang, Kai Zhang, Chunfang Qin
The International Journal of Lower Extremity Wounds.2024; 23(1): 70. CrossRef
Classification of foot ulcers in people with diabetes: A systematic review
Matilde Monteiro‐Soares, Emma J. Hamilton, David A. Russell, Gulapar Srisawasdi, Edward J. Boyko, Joseph L. Mills, William Jeffcoate, Fran Game
Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef
Atherogenic markers and 1-year amputation risk in adults with diabetic foot in a tertiary level hospital: A retrospective cohort study
Jerry K. Benites-Meza, Jussara Malo-Castillo, Percy Herrera-Añazco, Vicente A. Benites-Zapata
Journal of Diabetes and its Complications.2024; 38(9): 108810. CrossRef
Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus
Dhruv Nandakumar, Matthew J. Johnson, Lawrence A. Lavery, Benjamin M. Conover, Katherine M. Raspovic, David H. Truong, Dane K. Wukich
Journal of Diabetes and its Complications.2024; 38(11): 108876. CrossRef
Analysis of clinical characteristics in patients with diabetic foot ulcers undergoing amputation and establishment of a nomogram prediction model
Tiantian Xu, Lianqi Hu, Banglin Xie, Gendong Huang, Xiaolong Yu, Fengbo Mo, Wei Li, Meisong Zhu
Scientific Reports.2024;[Epub] CrossRef
Survival rate of diabetic-related lower extremity amputees in hospitals in the Eastern Cape
Aviwe S. Mgibantaka, Alfred Musekiwa, Moleen Zunza
African Journal of Disability.2024;[Epub] CrossRef
Renal function is highly associated with podiatric risk in diabetic patients
Jean-Baptiste Bonnet, Ilan Szwarc, Antoine Avignon, Sébastien Jugant, Ariane Sultan
Clinical Kidney Journal.2023; 16(11): 2156. CrossRef
Risk factor analysis for diabetic foot ulcer‐related amputation including Controlling Nutritional Status score and neutrophil‐to‐lymphocyte ratio
Yandan Zhu, Hongtao Xu, Yuzhen Wang, Xia Feng, Xinyu Liang, Liying Xu, Zhiqiang Liang, Zhongjia Xu, Yawen Li, Yi Le, Manchen Zhao, Jianfei Yang, Ji Li, Yemin Cao
International Wound Journal.2023; 20(10): 4050. CrossRef
The association between estimated glomerular filtration rate and prognosis in patients with diabetic foot osteomyelitis
Jinghang Zhang, Dong Chen, Xuemei Li, Min Ding, Jun Xu, Meijun Wang, Bai Chang
International Wound Journal.2022; 19(7): 1650. CrossRef
Renal Function Status in Patients with Diabetes Mellitus Having Diabetic Foot Infection and Role of Antibiotics
Shabab Hussain, . Arrham, Syeda Javeriya Saeed, Ahmad Murtaza Anwar, Asif Khan, Saifullah Brohi
Pakistan Journal of Health Sciences.2022; : 189. CrossRef
Re-understanding and focusing on normoalbuminuric diabetic kidney disease
Na An, Bi-tao Wu, Yu-wei Yang, Zheng-hong Huang, Jia-fu Feng
Frontiers in Endocrinology.2022;[Epub] CrossRef
The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double‐blind, placebo‐controlled trial
Mehrdad Mokhtari, Reza Razzaghi, Mansooreh Momen‐Heravi
Phytotherapy Research.2021; 35(4): 2099. CrossRef
Prevalence of Sarcopenia and Its Association With Diabetes: A Meta-Analysis of Community-Dwelling Asian Population
Seung Min Chung, Jun Sung Moon, Min Cheol Chang
Frontiers in Medicine.2021;[Epub] CrossRef
Clinical outcomes among patients with chronic kidney disease hospitalized with diabetic foot disorders: A nationwide retrospective study
Michael Salim
Endocrinology, Diabetes & Metabolism.2021;[Epub] CrossRef
Diabetic foot infections: Profile and antibiotic susceptibility patterns of bacterial isolates in a tertiary care hospital of Oman
Mohan Bilikallahalli Sannathimmappa, Vinod Nambiar, Rajeev Aravindakshan, Mohammad Saleem Jawad Al Khabori, Asma Hamed Sulaiman Al-Flaiti, Kadhiya Nasser Mohamed Al-Azri, Ali Khamis Saif Al-Reesi, Alya Rashid Mohammad Al Kiyumi
Journal of Education and Health Promotion.2021;[Epub] CrossRef

Cardiology and Cardiovascular Medicine
Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery: Bo Eun Park, Myung Hwan Bae, Hyeon Jeong Kim, Yoon Jung Park, Hong Nyun Kim, Se Yong Jang, Jang Hoon Lee, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae; Yeungnam Univ J Med. 2020;37(4):321-328. Published online July 16, 2020; DOI: https://doi.org/10.12701/yujm.2020.00353

10,458 View
111 Download
4 Crossref

Abstract PDF

Background
This study aimed to investigate the incidences of and risk factors for perioperative events following anticoagulant discontinuation in patients with non-valvular atrial fibrillation (NVAF) undergoing non-cardiac surgery.
Methods
A total of 216 consecutive patients who underwent cardiac consultation for suspending perioperative anticoagulants were enrolled. A perioperative event was defined as a composite of thromboembolism and major bleeding.
Results
The mean anticoagulant discontinuation duration was 5.7 (±4.2) days and was significantly longer in the warfarin group (p<0.001). Four perioperative thromboembolic (1.85%; three strokes and one systemic embolization) and three major bleeding events (1.39%) were observed. The high CHA2DS2-VASc and HAS-BLED scores and a prolonged preoperative anticoagulant discontinuation duration (4.4±2.1 vs. 2.9±1.8 days; p=0.028) were associated with perioperative events, whereas the anticoagulant type (non-vitamin K antagonist oral anticoagulants or warfarin) was not. The best cut-off levels of the HAS-BLED and CHA2DS2-VASc scores were 3.5 and 2.5, respectively, and the preoperative anticoagulant discontinuation duration for predicting perioperative events was 2.5 days. Significant differences in the perioperative event rates were observed among the four risk groups categorized according to the sum of these values: risk 0, 0%; risk 1, 0%; risk 2, 5.9%; and risk 3, 50.0% (p<0.001). Multivariate logistic regression analysis showed that the HAS-BLED score was an independent predictor for perioperative events.
Conclusion
Thromboembolic events and major bleeding are not uncommon during perioperative anticoagulant discontinuation in patients with NVAF, and interrupted anticoagulation strategies are needed to minimize these.

Citations

Citations to this article as recorded by

Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study
Alba Scerrati, Giorgio Mantovani, Michele Alessandro Cavallo, Maria Elena Flacco, Pietro Zangrossi, Silvia Eichner, Luca Ricciardi, Antonella Mangraviti, Antonino Raco, Tamara Ius, Daniele Piccolo, Oriela Rustemi, Fabio Raneri, Carmelo Lucio Sturiale, Alb
Neurosurgical Review.2025;[Epub] CrossRef
Clinical outcomes and hemorrhagic or thromboembolic risks in decompressive craniectomy for patients taking antiplatelet or anticoagulant therapy
Alba Scerrati, Giovanni Scanferla, Lorenzo Sgarbanti, Giorgio Mantovani, Chiara Angelini, Maria Elena Flacco, Rosario Maugeri, Lapo Bonosi, Domenico Gerardo Iacopino, Silvana Tumbiolo, Alessandro Adorno, Lara Brunasso, Giorgio Lofrese, Vittoria Rosetti, L
Neurosurgical Review.2025;[Epub] CrossRef
Development of a nomogram for prediction of postoperative bleeding after transurethral resection of bladder tumors
Paloma Pellegrino, Thomas Paul Scherer, Marian Severin Wettstein, Melanie Baumgartner, Daniel Eberli, Cédric Poyet, Uwe Bieri
International Urology and Nephrology.2025; 58(3): 921. CrossRef
Bleeding risk in female patients undergoing intravesical injection of onabotulinumtoxinA for overactive bladder: a Danish retrospective cohort study
Meryam El Issaoui, Sophia Elissaoui, Marlene Elmelund, Niels Klarskov
International Urogynecology Journal.2023; 34(10): 2581. CrossRef

Case reports

Neurology
Negative myoclonus associated with tramadol use: Seong Yoon Bae, Se-Jin Lee; Yeungnam Univ J Med. 2020;37(4):329-331. Published online April 23, 2020; DOI: https://doi.org/10.12701/yujm.2020.00108

11,304 View
184 Download
3 Crossref

Abstract PDF

Negative myoclonus (NM) is a shock-like jerky involuntary movement caused by a sudden, brief interruption of tonic muscle contraction. NM is observed in patients diagnosed with epilepsy, metabolic encephalopathy, and drug toxicity and in patients with brain lesions. A 55-year-old man presented with NM in both his arms and neck. He has taken medications containing tramadol at a dose of 80–140 mg/day for 5 days due to common cold. He had no history of seizures. Acute lesions were not observed during magnetic resonance imaging, and abnormal findings in his laboratory tests were not noted. His NM resolved completely after the discontinuation of tramadol and the oral administration of clonazepam. Our case report suggests that tramadol can cause NM in patients without seizure history or metabolic disorders, even within its therapeutic dose.

Citations

Citations to this article as recorded by

Drug-Induced Myoclonus: A Systematic Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Nidhi Bhal, Rishikulya Repudi, Lea Zlatin, Ian M. Walker
Medicina.2025; 61(1): 131. CrossRef
Tramadol use and risk of seizure: A report of two cases and a review of recent literature
Emma Dolan, Norman Delanty
Epilepsy & Behavior Reports.2025; 30: 100763. CrossRef
Tramadol Induced Jerks
Waiz Wasey, Imad Aziz, Sharefi Saleh, Naila Manahil, Neha Wasey
Cureus.2021;[Epub] CrossRef

Pediatrics, Perinatology, and Child Health
Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn’s disease who turned out to possess homozygous mutations in NUDT15 R139C: Jaewoan Bae, Byung-Ho Choe, Ben Kang; Yeungnam Univ J Med. 2020;37(4):332-336. Published online May 22, 2020; DOI: https://doi.org/10.12701/yujm.2020.00178

8,951 View
91 Download
4 Crossref

Abstract PDF

Homozygous mutations in NUDT15 R139C are known as the major factor associated with thiopurine-induced early leukopenia, particularly in Asian patients. Therefore, NUDT15 genotyping is currently recommended before thiopurine treatment to identify patients who are NUDT15 poor metabolizers and consider the use of an alternative immunomodulatory therapy. We report a case of a 12-year-old Korean girl with Crohn’s disease (CD), in whom thiopurine-induced leukopenia was prevented by initiation of azathioprine (AZA) therapy at a low dose (0.5 mg/kg/day) and early detection of significant hair loss and white blood cell (WBC) count decrease at 17 days from the start of AZA treatment. The WBC count dropped from 8,970/μL to 3,370/μL in 2 weeks, and AZA treatment was stopped because of concerns of potential leukopenia in the near future. Her WBC count recovered to 5,120/μL after 3 weeks. Gene analysis later revealed that she had a homozygous mutation in NUDT15 R139C, resulting in a poor metabolizing activity of NUDT15. In situations when NUDT15 genotyping is unavailable, initiation of AZA therapy at 0.5 mg/kg/day with close observation of hair loss and WBC counts within 2 weeks may be an alternative way to prevent thiopurine-induced early leukopenia in Asian children with CD.

Citations

Citations to this article as recorded by

NUDT15 Pharmacogenetics in Acute Lymphoblastic Leukemia: Synthesizing Progress for Personalized Thiopurine Therapy
Isfahan Shah Lubis, Kusnandar Anggadiredja, Aluicia Anita Artarini, Nur Melani Sari, Nur Suryawan, Zulfan Zazuli
Medical Sciences.2025; 13(3): 112. CrossRef
Identification of Candidate Genes for Min Pig Villi Hair Traits by Genome-Wide Association of Copy Number Variation
Xinmiao He, Ming Tian, Wentao Wang, Yanzhong Feng, Zhongqiu Li, Jiahui Wang, Yan Song, Jinfeng Zhang, Di Liu
Veterinary Sciences.2023; 10(5): 307. CrossRef
Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review
Juan Gu, Yupei Lin, Yuhe Wang
Frontiers in Pharmacology.2023;[Epub] CrossRef
KASL clinical practice guidelines for management of autoimmune hepatitis 2022

Clinical and Molecular Hepatology.2023; 29(3): 542. CrossRef

Urology
Ureterosciatic hernia causing obstructive uropathy successfully managed with minimally invasive procedures: Yeong Uk Kim, Jae Ho Cho, Phil Hyun Song; Yeungnam Univ J Med. 2020;37(4):337-340. Published online July 29, 2020; DOI: https://doi.org/10.12701/yujm.2020.00402

8,993 View
107 Download
3 Crossref

Abstract PDF

Ureterosciatic hernia is extremely rare. In ureteral herniation, ureter prolapses occur through either the greater or lesser sciatic foramen. Atrophy of the piriformis muscle, hip joint diseases, and defects in the parietal pelvic fascia are predisposing factors for the development of ureterosciatic hernia. Most symptomatic patients have been treated surgically, with conservative treatment reserved only for asymptomatic patients. To the best of our knowledge, long-term follow-up outcomes after ureterosciatic hernia management are sparse. In this paper, we report the case of a 68-year-old woman who presented with colicky left abdominal pain. After computed tomography (CT) scan and anterograde pyelography, she was diagnosed ureterosciatic hernia with obstructive uropathy. We performed ureteral balloon dilatation and double-J ureteral stent placement. After this minimally invasive procedure, CT scan demonstrated that the left ureter had returned to its normal anatomical position without looping into the sciatic foramen. The patient remained asymptomatic with no adverse events 7 years after the minimally invasive procedures. This brief report describes ureterosciatic hernia successfully managed with minimally invasive procedures with long-term follow-up outcomes.

Citations

Citations to this article as recorded by

Management of sciatic hernia as a unique cause of hip pain: laparoscopic transabdominal preperitoneal (TAPP) repair with LiquiBandFIX8 anchoring technique
Hannah Mathews, Balakrishnan Saravanan, Paul Wilson
BMJ Case Reports.2025; 18(9): e267492. CrossRef
Ureterosciatic Hernia in Focus: A Narrative Review of the Literature
Mohamed Mustafa, Afiq Pouzi, Peter Senada, Lokesh Suraparaju, Suresh Gupta
Cureus.2023;[Epub] CrossRef
Urosepsis secondary to ureterosciatic hernia corrected with ureteral stent placement: a case report and literature review
Kohei Kakimoto, Mayu Hikone, Ko Nagai, Jun Yamakawa, Kazuhiro Sugiyama, Yuichi Hamabe
International Journal of Emergency Medicine.2021;[Epub] CrossRef

Emergency and Critical Care Medicine
Clinical characteristics of hereditary neuropathy with liability to pressure palsy presenting with monoparesis in the emergency department: Changho Kim, Jin-Sung Park; Yeungnam Univ J Med. 2020;37(4):341-344. Published online July 31, 2020; DOI: https://doi.org/10.12701/yujm.2020.00472

19,018 View
107 Download
2 Crossref

Abstract PDF

Hereditary neuropathy with liability to pressure palsy (HNPP) is a rare neurological genetic disease caused by deletion of the peripheral myelin protein 22 gene and presents in childhood or young adulthood. We report four cases of HNPP with typical and rare presentations, reflecting the broad clinical spectrum of this disease. Two patients presented with mononeuropathies that are frequently observed in HNPP; the remaining two presented with bilateral neuropathy or mononeuropathy anatomically present in the deep layer. This reflects the broad clinical presentation of HNPP, and clinicians should differentiate these conditions in young patients with monoparesis or bilateral paresis. Although HNPP is currently untreatable, early diagnosis in the emergency department can lead to early detection, eventually resulting in less provocation and recurrence which may cause early motor nerve degeneration.

Citations

Citations to this article as recorded by

Literature review of clinical analysis of hereditary neuropathy with liability to pressure palsies
Limin Chen, Hongbo Zhang, Chunnv Li, Nuo Yang, Jiangtao Wang, Jianmin Liang
Journal of Neurology.2025;[Epub] CrossRef
A 30-year-old male patient who experienced recurring weakness in bilateral upper and lower extremities: a clinical vignette
Soo Hyun Ahn, Mathieu Boudier-Revéret, Seoyon Yang, Min Cheol Chang
Journal of Yeungnam Medical Science.2025; 42: 27. CrossRef

Cardiology and Cardiovascular Medicine
Early surgical intervention for unusually located cardiac fibroelastomas: Eui Suk Chung, Jae Hoon Lee, Jong Kwon Seo, Byung Gyu Kim, Gwang Sil Kim, Hye Young Lee, Young Sup Byun, Hyun Jung Kim; Yeungnam Univ J Med. 2020;37(4):345-348. Published online August 5, 2020; DOI: https://doi.org/10.12701/yujm.2020.00556

7,308 View
57 Download
2 Crossref

Abstract PDF

Papillary fibroelastomas are the second most common primary cardiac tumor in adults. Over 80% of fibroelastomas occur on the cardiac valves, usually on the left side of the heart, while the remaining lesions are typically scattered throughout the atria and ventricles. Although the optimal timing for surgery is controversial and depends on tumor size and location, prompt surgical resection is warranted in patients at high risk of embolism. A tumor on the cardiac valve can be removed using the slicing excision technique without leaflet injury. Here we present two cases of papillary fibroelastomas occurring on the ventricular surface of the aortic valve and in the right ventricle.

Citations

Citations to this article as recorded by

A Importância da Multimodalidade de Imagem no Diagnóstico de um Raro Caso de Fibroelastoma Papilar no Ápice do Ventrículo Esquerdo
Marcio Mendes Pereira, Vinícius José da Silva Nina, José Xavier de Melo Filho, Rodrigo de Jesus Louzeiro Melo, Marco Túlio Hercos Juliano, Luma Sayonara Martins Pereira
ABC Imagem Cardiovascular.2023;[Epub] CrossRef
The Importance of Imaging Multimodality in the Diagnosis of a Rare Case of Papillary Fibroelastoma in the Left Ventricular Apex
Marcio Mendes Pereira, Vinícius José da Silva Nina, José Xavier de Melo, Rodrigo de Jesus Louzeiro Melo, Marco Túlio Hercos Juliano, Luma Sayonara Martins Pereira
ABC Imagem Cardiovascular.2023;[Epub] CrossRef

Communications

Infectious Disease
Yeungnam University type drive-through (YU-Thru) coronavirus disease 2019 (COVID-19) screening system: a rapid and safe screening system: Wan Seok Seo, Seong Ho Kim, Si Youn Song, Jian Hur, Jun Lee, Sunho Choi, Yoojung Lee, Dai Seg Bai; Yeungnam Univ J Med. 2020;37(4):349-355. Published online September 18, 2020; DOI: https://doi.org/10.12701/yujm.2020.00640

13,756 View
102 Download
3 Crossref

Abstract PDF

Active and prompt scale-up screening tests are essential to efficiently control the coronavirus disease 2019 (COVID-19) outbreak. The goal of this work was to identify shortcomings in the conventional screening system (CSS) implemented in the beginning of the outbreak. To overcome these shortcomings, we then introduced a novel, independently developed system called the Yeungnam University type drive-through (YU-Thru), and distributed it nationwide in Korea. This system is similar to the drive-throughs utilized by fast food restaurants. YU-Thru system has shortened the time taken to test a single person to 2–4 minutes, by completely eliminating the time required to clean and ventilate the specimen collection room. This time requirement was a major drawback of the CSS. YU-Thru system also reduced the risk of subjects and medical staff infecting one another by using a separate and closed examination system. On average, 50 to 60 tests were conducted per day when using the CSS, while now up to 350 tests per day are conducted with the YU-Thru system. We believe that the YU-Thru system has made an important contribution to the rapid detection of COVID-19 in Daegu, South Korea. Here, we will describe the YU-Thru system in detail so that other countries experiencing COVID-19 outbreaks can take advantage of this system.

Citations

Citations to this article as recorded by

Experience of operating a medical humanities course at one medical school during the COVID-19: a retrospective study
Yu Ra Kim, Hye-won Shin, Young Hwan Lee, Seong-Yong Kim
Journal of Yeungnam Medical Science.2023; 40(2): 179. CrossRef
Lessons Learned From an Analysis of the Emergency Medical Services’ COVID-19 Drive-Through Testing Facilities in Israel
Itay Zmora, Evan Avraham Alpert, Uri Shacham, Nisim Mishraki, Eli Jaffe
Disaster Medicine and Public Health Preparedness.2022; 16(5): 2091. CrossRef
A study on the mental health of students at a medical school during COVID-19 outbreak: a retrospective study
Yu Ra Kim, Hye Jin Park, Bon-Hoon Koo, Ji Young Hwang, Young Hwan Lee
Journal of Yeungnam Medical Science.2022; 39(4): 314. CrossRef

First
Prev
Page of 1
Next
Last

Previous issues